Beqalzi

Generic name: sonrotoclax

Used for: Mantle cell lymphoma that came back or didn’t respond

How do you pay?

How to pay the least

Ask for the cash price

Beqalzi

We didn’t find one.

  1. Ask your pharmacy for Beqalzi’s cash price, and one or two other pharmacies too.

Compare every option

Question
Brand nameBeqalzi
Authorized genericsonrotoclax
Regular genericsonrotoclax
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Beqalzi?
The original
–
–

Brand nameNo maker’s card

We didn’t find a savings card or cash price from Beqalzi’s maker. Ask the pharmacy for Beqalzi’s cash price. With insurance, ask what your plan charges.

Authorized genericNot sold

There isn’t one. An authorized generic is Beqalzi itself, from the same company, sold without the brand name, and usually for less. For now Beqalzi is the only choice; ask the pharmacy for its cash price, or your plan what it charges.

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, ask the pharmacy for Beqalzi’s cash price, or your plan what it charges.

What it’s used for

What the FDA label says

BEQALZI is a BCL-2 inhibitor indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic therapy, including a Bruton's tyrosine kinase (BTK) inhibitor.

This indication is approved under accelerated approval based on response rate and durability of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).

Source: the FDA label for Beqalzi (BeOne Medicines USA, Inc.), September 25, 2026. Full label on DailyMed 

Good to know

Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/beqalzi/